Operations Global Graduate Associates Programme - US
AstraZeneca
Summary
Our two-year rotational programme prepares you for accelerated entry into an impactful role, helping shape your future within AstraZeneca's Operations organisation. Starting in September 2027, graduates will join one of three pathways within the programme.
Job description
About the Programme
Our two-year rotational programme prepares you for accelerated entry into an impactful role, helping shape your future within AstraZeneca's Operations organisation. Starting in September 2027, graduates will join one of three pathways within the programme.
Operations Pathway
Designed for those interested in manufacturing and operations, this pathway provides experience across our production network and supply chain. Graduates will typically begin at our Newark, DE, Coppell, TX or Mt. Vernon, IN sites and rotate to other locations throughout the programme.
- Technical or engineering-focused experience
- Manufacturing site operations, supply chain, quality or production support
- A global Operations function or strategic project
Pharmaceutical Technology & Development (PT&D) Pathway
Designed for those interested in pharmaceutical science and product development, this pathway provides experience across the lifecycle of a medicine, from development through commercialisation. Rotations will primarily be based in Durham, NC.
- Product or process development
- Laboratory-based, technical or scientific experience
- A global PT&D function, digital capability area or a strategic project
Global Engineering Pathway
Designed for those interested in engineering and capital project delivery, this pathway provides hands-on experience across the full lifecycle of major projects, while developing technical, leadership and project management skills that support AstraZeneca's global manufacturing and R&D network. Rotations will be based in Gaithersburg, MD.
- Front end studies and project definition
- Capital project delivery and project management
- Technical engineering and design
- Sustainability and digital engineering initiatives
Programme Highlights
- Meaningful Impact: Work on challenging projects and contribute to healthcare advancements
- Global Environment: Contribute to projects with global impact and collaborate with global colleagues
- Global Experience: Take part in 3 global cohort meet-ups across the two-year programme
- Mentorship and Career Development: Tailored mentorship, structured training, and development opportunities
- Community: Join an open environment where every voice is valued and heard
Requirements
- Bachelor's or Master's degree awarded in 2026 or due to be awarded in 2027
- Degree discipline relevant to chosen pathway: Operations Pathway: Engineering, Supply Chain Management, Manufacturing Technology, Biological or Physical Sciences, or a related field
- PT&D Pathway: Chemistry, Pharmacy/Pharmaceutical Sciences, Chemical, Mechanical or Device Engineering, Physics, Data Science, Biosciences, or a related field
- Global Engineering Pathway: Open to all engineering disciplines
- A strong motivation to pursue a career aligned to chosen pathway
- Commitment to contributing to the development, manufacture and delivery of life-changing medicines
- Curiosity, adaptability and a willingness to step outside comfort zone
- Strong communication skills (verbal and written)
- 0-2 years of experience required
Benefits
- Annual bonus
- Vacation
- Sick leave
- Health insurance
- Dental insurance
- Vision insurance
- 401(k)
Company overview
AstraZeneca is a global, science-led, patient-focused pharmaceutical company dedicated to accelerating the delivery of life-changing medicines that create enduring value for patients, society, and shareholders. With a workforce of over 94,300 employees worldwide, the company operates across three core therapy areas: Oncology, BioPharmaceuticals (including Cardiovascular, Renal & Metabolism, Respiratory & Immunology), and Rare Disease. Headquartered in Cambridge, UK, AstraZeneca maintains strategic R&D centers in Cambridge, Gaithersburg (US), Boston (US), Gothenburg (Sweden), Shanghai, and Beijing. The company generated $54.1 billion in total revenue in 2024 and invested $13.6 billion in scientific research and development. AstraZeneca's bold aspiration is to be pioneers in science, lead in disease areas, and transform patient outcomes, with a goal to launch 20 new medicines and achieve $80 billion in total revenue by 2030. The company is recognized for its commitment to sustainability, health equity, and creating an inclusive work environment where diverse perspectives drive innovation.